Search
Search Results
##search.searchResults.foundPlural##
-
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2855PDF: 1012HTML: 4724 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
3189PDF: 1306HTML: 11860 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3721PDF: 1152HTML: 23375 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6261PDF: 3435HTML: 9059Figure Malaria Ricci: 260 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4292PDF: 2019HTML: 1956 -
ADVANCES IN THE TREATMENT OF MALARIA
2919PDF: 1338HTML: 6145 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2140PDF: 882HTML: 362 -
RELIABILITY OF DIFFERENT RBC INDICES AND FORMULAS IN DISCRIMINATING BETWEEN ?-THALASSEMIA MINOR AND OTHER CAUSES OF MICROCYTIC HYPOCHROMIC ANEMIA
3111PDF: 1665HTML: 14668Untitled: 235Untitled: 195 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2503PDF: 1638HTML: 703 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1094PDF: 958Suppl. Files: 611HTML: 104 -
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2283PDF: 1480HTML: 971 -
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1359PDF: 947HTML: 337 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
762PDF: 482HTML: 6281 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1851PDF: 909HTML: 1473 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4924PDF: 1860HTML: 2866Untitled: 251 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2450PDF: 1912HTML: 172 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3426PDF: 1286HTML: 8394 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1625PDF: 1873Suppl. Files: 182HTML: 107 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3455PDF: 1370HTML: 6344 -
-
THE PERFORMANCE OF HOMA 2 COMPARED TO DYNAMIC MARKERS OF INSULIN SECRETION AND SENSITIVITY/RESISTANCE FOR PREDICTING DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: THE EXPERIENCE OF A SINGLE CENTRE HOMA 2 and DYNAMIC MARKERS OF INSULIN SECRETION FOR PREDICTING DYSGLYCEMIA in TDT
196PDF: 189HTML: 49 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2377PDF: 1363HTML: 17204Bassan Fig.1: 161Bassan Fig.2: 264Bassan Fig.4: 154Fig.3: 226 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2961PDF: 1153HTML: 3075 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1248PDF: 865HTML: 3416 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
806PDF: 682HTML: 126 -







